梯瓦制药(TEVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TEVA 梯瓦制药

休市中 08-23 16:00:00 EDT

18.56

+0.17

+0.92%

盘后18.57

+0.01+0.05%

19:53 EDT

最高18.57	最低18.27	成交量513.33万
今开18.47	昨收18.39	日振幅1.63%
总市值210.28亿	流通市值209.04亿	总股本11.33亿
成交额9,486万	换手率0.46%	流通股本11.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TEVA","market":"US","secType":"STK","nameCN":"梯瓦制药","latestPrice":18.56,"timestamp":1724443200000,"preClose":18.39,"halted":0,"volume":5133296,"hourTrading":{"tag":"盘后","latestPrice":18.57,"preClose":18.56,"latestTime":"19:53 EDT","volume":272399,"amount":5055742.9015,"timestamp":1724457214612},"delay":0,"floatShares":1126276697,"shares":1132992397,"eps":-0.403024,"marketStatus":"休市中","marketStatusCode":7,"change":0.17,"latestTime":"08-23 16:00:00 EDT","open":18.47,"high":18.57,"low":18.27,"amount":94855286.738352,"amplitude":0.016313,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.403024,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"adjPreClose":18.39,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":18.47,"preClose":18.39,"latestTime":"09:27 EDT","volume":1184,"amount":21884.1384,"timestamp":1724419653513},"postHourTrading":{"tag":"盘后","latestPrice":18.57,"preClose":18.56,"latestTime":"19:53 EDT","volume":272399,"amount":5055742.9015,"timestamp":1724457214612},"volumeRatio":0.9115065697475666,"optionData":{"bulkOrders":[{"symbol":"TEVA","call":true,"expireDate":1724990400000,"strike":"19.5","timestamp":1724427049799,"price":0.029999999329447746,"volume":10000,"amount":30000,"type":"-"},{"symbol":"TEVA","call":false,"expireDate":1737090000000,"strike":"16.0","timestamp":1724433826134,"price":0.7400000095367432,"volume":3493,"amount":258482,"type":"+"}]},"impliedVol":0.4776,"impliedVolPercentile":0.7103},"requestUrl":"/m/hq/s/TEVA/wiki","defaultTab":"wiki","newsList":[{"id":"2459766106","title":"梯瓦制药盘中异动 早盘急速上涨5.02%报17.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459766106","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459766106?lang=zh_cn&edition=full","pubTime":"2024-08-14 23:20","pubTimestamp":1723648852,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日23时20分，梯瓦制药股票出现波动，股价急速上涨5.02%。截至发稿，该股报17.99美元/股，成交量699.452万股，换手率0.62%，振幅4.85%。梯瓦制药股票所在的制药行业中，整体涨幅为1.76%。梯瓦一半的销售额来自北美，占美国仿制药处方总数的高个位数百分比。梯瓦还销售活性药物成分，提供合同生产服务，并拥有总部位于美国的仿制药和专科药物经销商 Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081423205397198bd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081423205397198bd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4566","BK4557","BK4007","TEVA","BK4559","BK4585","BK4584"],"gpt_icon":0},{"id":"2457753814","title":"梯瓦制药2024财年第二财季实现净利润-8.45亿美元，同比增加1.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457753814","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457753814?lang=zh_cn&edition=full","pubTime":"2024-08-05 00:15","pubTimestamp":1722788131,"startTime":"0","endTime":"0","summary":"8月5日，梯瓦制药公布财报，公告显示公司2024财年第二财季净利润为-8.45亿美元，同比增加1.97%；其中营业收入为41.62亿美元，同比增加7.21%，每股基本收益为-0.75美元。从资产负债表来看，梯瓦制药总负债347.74亿美元，其中短期债务20.94亿美元，资产负债比为1.19，流动比率为0.90。机构评级：截至2024年8月5日，当前有7家机构对梯瓦制药目标价做出预测，其中目标均价为21.29美元，其中最低目标价为16.00美元，最高目标价为24.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805001537957ca9c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805001537957ca9c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TEVA"],"gpt_icon":0},{"id":"2455137474","title":"梯瓦制药(TEVA.US)涨超5.4%报17.3美元。消息面上梯瓦制药第二季度营收41.6亿美元市场预估40.5亿美元；调整后EBITDA为11.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455137474","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455137474?lang=zh_cn&edition=full","pubTime":"2024-07-31 22:11","pubTimestamp":1722435105,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","TEVA","BK4585","BK4584","BK4559","BK4557","BK4566","BK4007"],"gpt_icon":0},{"id":"2455497132","title":"美股异动｜梯瓦制药涨超5.4% Q2营收及全年营收指引均超预期梯瓦制药(TEVA.US)涨超5.4%，报17.3美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455497132","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455497132?lang=zh_cn&edition=full","pubTime":"2024-07-31 22:07","pubTimestamp":1722434859,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["TEVA","BK4557","BK4566","BK4007","BK4559","BK4588","BK4584","BK4585"],"gpt_icon":0},{"id":"2455371551","title":"美股异动｜梯瓦制药涨超5.4% Q2营收及全年营收指引均超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2455371551","media":"港股那点事","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455371551?lang=zh_cn&edition=full","pubTime":"2024-07-31 22:07","pubTimestamp":1722434820,"startTime":"0","endTime":"0","summary":"格隆汇7月31日｜梯瓦制药(TEVA.US)涨超5.4%，报17.3美元。消息面上，梯瓦制药第二季度营收41.6亿美元，市场预估40.5亿美元；调整后EBITDA为11.7亿美元，市场预估11.4亿美元；调整后每股收益0.61美元。该公司预计全年营收160亿至164亿美元，市场预估160.1亿美元；调整后EBITDA为46亿至50亿美元，市场预估47.8亿美元。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/bxjj/2024-07-31/doc-incfzyqs6771967.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-07-31/doc-incfzyqs6771967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["TEVA"],"gpt_icon":0},{"id":"1170678524","title":"异动解读 | 梯瓦制药(TEVA)盘中大涨6.67% 二季度业绩超预期引发利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1170678524","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170678524?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:42","pubTimestamp":1722433327,"startTime":"0","endTime":"0","summary":"梯瓦制药今日盘中股价大涨6.67%,报16.7美元,引发市场广泛关注。这主要受到该公司公布的第二季度业绩超预期以及上调全年指引的利好消息所推动。财报数据显示,梯瓦制药第二季度营收为41.6亿美元,高于市场预期的40.5亿美元。值得一提的是,梯瓦制药还上调了全年业绩指引。公司预计全年营收将达到160亿至164亿美元,调整后EBITDA为46亿至50亿美元,调整后每股收益为2.30至2.50美元,均高于此前市场预期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA"],"gpt_icon":0},{"id":"2455390631","title":"梯瓦制药盘中异动 早盘股价大涨5.06%报17.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455390631","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455390631?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:31","pubTimestamp":1722432673,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日21时31分，梯瓦制药股票出现波动，股价快速拉升5.06%。截至发稿，该股报17.24美元/股，成交量76.7726万股，换手率0.07%，振幅0.61%。梯瓦制药股票所在的制药行业中，整体跌幅为0.06%。梯瓦一半的销售额来自北美，占美国仿制药处方总数的高个位数百分比。梯瓦还销售活性药物成分，提供合同生产服务，并拥有总部位于美国的仿制药和专科药物经销商 Anda。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073121311396822456&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073121311396822456&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","TEVA","BK4007","BK4559","BK4557","BK4585","BK4584","BK4566"],"gpt_icon":0},{"id":"1175521884","title":"异动解读 | 梯瓦制药(TEVA)盘前大涨5.24% 二季度业绩超预期引发利好","url":"https://stock-news.laohu8.com/highlight/detail?id=1175521884","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175521884?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:24","pubTimestamp":1722432259,"startTime":"0","endTime":"0","summary":"梯瓦制药今日盘前大涨5.24%,报16.7美元。这主要受到该公司公布的第二季度业绩超预期以及上调全年指引的利好消息所推动。财报数据显示,梯瓦制药第二季度营收为41.6亿美元,高于市场预期的40.5亿美元。调整后EBITDA为11.7亿美元,也超过了分析师预估的11.4亿美元。值得一提的是,梯瓦制药还上调了全年业绩指引。公司预计全年营收将达到160亿至164亿美元,调整后EBITDA为46亿至50亿美元,调整后每股收益为2.30至2.50美元,均高于此前市场预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA"],"gpt_icon":0},{"id":"2455139068","title":"Teva Pharmaceutical Indus(TEVA.US)：2024年Q2财报实现营收41","url":"https://stock-news.laohu8.com/highlight/detail?id=2455139068","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455139068?lang=zh_cn&edition=full","pubTime":"2024-07-31 20:56","pubTimestamp":1722430596,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Indus(TEVA.US)：2024年Q2财报实现营收41.64亿美元，前值为38.78亿美元，预期值为40.6亿美元；每股收益为0.61美元，前值为0.56美元，预期值为0.55美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407312107349571797b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407312107349571797b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TEVA"],"gpt_icon":0},{"id":"2455874981","title":"梯瓦制药(TEVA)盘前涨超1% 二季度营收41.6亿美元 高于市场预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2455874981","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455874981?lang=zh_cn&edition=full","pubTime":"2024-07-31 19:50","pubTimestamp":1722426647,"startTime":"0","endTime":"0","summary":"金吾财讯 | 梯瓦制药(TEVA)盘前涨超1%，截止发稿，报16.7美元。消息面上，梯瓦制药第二季度营收41.6亿美元，市场预估40.5亿美元。调整后EBITDA11.7亿美元，市场预估11.4亿美元。调整后每股收益0.61美元。预计全年营收160亿美元至164亿美元，市场预估160.1亿美元。预计全年调整后EBITDA46亿美元至50亿美元，市场预估47.8亿美元。预计全年调整后每股收益2.30美元至2.50美元。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210625/OGIwZDQyMDYwMGIwOWQ1NTkxMDE1Mzc1NTA2MDQ=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OGIwZDQyMDYwMGIwOWQ1NTkxMDE1Mzc1NTA2MDQ=.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"278411","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEVA"],"gpt_icon":0},{"id":"2455189002","title":"梯瓦制药（TEVA）第二季度营收41.6亿美元市场预估40.5亿美元。第二季度调整后EBITDA 11.7亿美元市场预估11.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455189002","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455189002?lang=zh_cn&edition=full","pubTime":"2024-07-31 19:19","pubTimestamp":1722424795,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4566","BK4584","TEVA","BK4007","BK4585","BK4557","BK4559","BK4588"],"gpt_icon":0},{"id":"2455189354","title":"梯瓦制药（TEVA）第二季度营收41.6亿美元，市场预估40.5亿美元。第二季度调整后EBITDA 11.7亿美元，市场预估11.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455189354","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455189354?lang=zh_cn&edition=full","pubTime":"2024-07-31 19:14","pubTimestamp":1722424479,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/us-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/us-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4557","BK4007","TEVA","BK4566","BK4559","BK4584","BK4585","BK4588"],"gpt_icon":0},{"id":"2450587745","title":"瑞银：维持Teva Pharmaceutical Indus(TEVA.US)评级，由买入调整至买入评级, 目标价由22.","url":"https://stock-news.laohu8.com/highlight/detail?id=2450587745","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450587745?lang=zh_cn&edition=full","pubTime":"2024-07-11 10:11","pubTimestamp":1720663886,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4557","BK4566","BK4584","BK4007","BK4559","BK4588","TEVA"],"gpt_icon":0},{"id":"2450505848","title":"梯瓦制药盘中异动 股价大涨5.00%报16.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450505848","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450505848?lang=zh_cn&edition=full","pubTime":"2024-07-11 00:17","pubTimestamp":1720628245,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日00时17分，梯瓦制药股票出现波动，股价快速拉升5.00%。截至发稿，该股报16.60美元/股，成交量524.366万股，换手率0.46%，振幅3.32%。梯瓦制药股票所在的制药行业中，整体涨幅为1.12%。梯瓦还销售活性药物成分，提供合同生产服务，并拥有总部位于美国的仿制药和专科药物经销商 Anda。消息层面，截至00时17分，梯瓦制药股票正面舆情新闻比例50%。《瑞士银行维持梯瓦制药买入评级，上调目标价至24美元》资讯为影响梯瓦制药的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110017269681b962&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407110017269681b962&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4557","BK4566","BK4584","BK4007","BK4559","BK4588","TEVA"],"gpt_icon":0},{"id":"2448913456","title":"梯瓦制药美股盘中转跌，一度跌近1.6%。报道称，美国联邦贸易委员会（FTC）开始对梯瓦制药（TEVA）展开调查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448913456","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448913456?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:48","pubTimestamp":1719841711,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/us-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/us-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["BK4566","BK4585","BK4584","FTC","TEVA","BK4007","BK4557","BK4588","BK4559"],"gpt_icon":0},{"id":"2448913410","title":"TEVA制药ADR转跌并触及盘中低点。","url":"https://stock-news.laohu8.com/highlight/detail?id=2448913410","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448913410?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:46","pubTimestamp":1719841617,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4584","BK4559","BK4007","BK4557","BK4585","01477","TEVA","BK1574","BK4588","BK1191","BK4566"],"gpt_icon":0},{"id":"2446524485","title":"杰富瑞投资银行：维持Teva Pharmaceutical Indus(TEVA.US)评级，由买入调整至买入评级, 目标价由19.","url":"https://stock-news.laohu8.com/highlight/detail?id=2446524485","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446524485?lang=zh_cn&edition=full","pubTime":"2024-06-27 23:37","pubTimestamp":1719502628,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","BK4566","BK4557","BK4007","TEVA","BK4559","BK4585","BK4584"],"gpt_icon":0},{"id":"2446980083","title":"提醒：意外将Deckers Brands的Teva品牌标记为梯瓦制药现已撤回。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446980083","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446980083?lang=zh_cn&edition=full","pubTime":"2024-06-26 21:04","pubTimestamp":1719407086,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","TEVA","BK4585","BK4584","BK4559","BK4557","BK4566","BK4007"],"gpt_icon":0},{"id":"2441208601","title":"巴克莱：维持Teva Pharmaceutical Indus(TEVA.US)评级由增持调整至增持评级, 目标价由20.","url":"https://stock-news.laohu8.com/highlight/detail?id=2441208601","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441208601?lang=zh_cn&edition=full","pubTime":"2024-06-05 23:20","pubTimestamp":1717600853,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","TEVA","BK4007","BK4559","BK4557","BK4585","BK4584","BK4566"],"gpt_icon":0},{"id":"2436602408","title":"梯瓦制药2024财年第一财季实现净利润-1.39亿美元，同比增加32.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436602408","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2436602408?lang=zh_cn&edition=full","pubTime":"2024-05-17 00:21","pubTimestamp":1715876472,"startTime":"0","endTime":"0","summary":"3月31日，梯瓦制药公布财报，公告显示公司2024财年第一财季净利润为-1.39亿美元，同比增加32.52%；其中营业收入为38.32亿美元，同比增加4.84%，每股基本收益为-0.12美元。机构评级：截至2024年3月31日，当前有8家机构对梯瓦制药目标价做出预测，其中目标均价为18.00美元，其中最低目标价为15.00美元，最高目标价为20.00美元。梯瓦一半的销售额来自北美，在美国仿制药总数中所占的比例很高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405170021178b0f8c18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405170021178b0f8c18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TEVA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tevapharm.com","stockEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.1248},{"period":"3month","weight":0.1181},{"period":"6month","weight":0.4399},{"period":"1year","weight":0.9193},{"period":"ytd","weight":0.7778}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Teva Pharmaceutical Industries Limited于1944年2月13日在以色列注册成立。该公司是一家全球性制药公司，致力于帮助世界各地的患者获得负担得起的药物，并从改善健康的创新中受益。该公司的使命是成为仿制药、创新药和生物制药领域的全球领导者，改善患者的生活。该公司在全球开展业务，总部设在以色列，并在美国、欧洲和世界各地的许多其他市场都有重要业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.082657},{"month":2,"riseRate":0.416667,"avgChangeRate":-0.0137},{"month":3,"riseRate":0.5,"avgChangeRate":-0.007635},{"month":4,"riseRate":0.25,"avgChangeRate":-0.006929},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.013519},{"month":6,"riseRate":0.538462,"avgChangeRate":0.013933},{"month":7,"riseRate":0.615385,"avgChangeRate":0.035474},{"month":8,"riseRate":0.153846,"avgChangeRate":-0.066963},{"month":9,"riseRate":0.416667,"avgChangeRate":-0.018381},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.025531},{"month":11,"riseRate":0.666667,"avgChangeRate":0.053689},{"month":12,"riseRate":0.5,"avgChangeRate":-0.004471}],"exchange":"NYSE","name":"梯瓦制药","nameEN":"Teva Pharmaceutical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"梯瓦制药(TEVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供梯瓦制药(TEVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"梯瓦制药,TEVA,梯瓦制药股票,梯瓦制药股票老虎,梯瓦制药股票老虎国际,梯瓦制药行情,梯瓦制药股票行情,梯瓦制药股价,梯瓦制药股市,梯瓦制药股票价格,梯瓦制药股票交易,梯瓦制药股票购买,梯瓦制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"梯瓦制药(TEVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供梯瓦制药(TEVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}